Insmed (INSM) Revenue & Revenue Breakdown


OverviewForecastOwnershipFinancialsChartTranscripts

Insmed Revenue Highlights


Latest Revenue (Y)

$606.42M

Latest Revenue (Q)

$142.34M

Main Segment (Y)

Reportable Segment

Main Geography (Y)

UNITED STATES

Insmed Revenue by Period


Insmed Revenue by Year

DateRevenueChange
2025-12-31$606.42M66.73%
2024-12-31$363.71M19.17%
2023-12-31$305.21M24.39%
2022-12-31$245.36M30.19%
2021-12-31$188.46M14.63%
2020-12-31$164.41M20.48%
2019-12-31$136.47M1287.56%
2018-12-31$9.84M100.00%
2017-12-31-100.00%
2016-12-31-100.00%
2015-12-31--100.00%
2014-12-31$11.50M-
2013-12-31$11.50M100.00%
2012-12-31--100.00%
2011-12-31$4.42M-36.18%
2010-12-31$6.92M-33.28%
2009-12-31$10.37M-11.33%
2008-12-31$11.70M55.39%
2007-12-31$7.53M659.74%
2006-12-31$991.00K656.49%
2005-12-31$131.00K-4.38%
2004-12-31$137.00K-8.67%
2003-12-31$150.00K-92.33%
2002-12-31$1.96M560.47%
2001-12-31$296.00K393.33%
2000-12-31$60.00K5900.00%
1999-12-31$1.00K-

Insmed generated $606.42M in revenue during NA 2025, up 66.73% compared to the previous quarter, and up 368.84% compared to the same period a year ago.

Insmed Revenue by Quarter

DateRevenueChange
2025-09-30$142.34M32.52%
2025-06-30$107.42M15.72%
2025-03-31$92.82M-11.12%
2024-12-31$104.44M11.79%
2024-09-30$93.42M3.41%
2024-06-30$90.34M19.66%
2024-03-31$75.50M-9.79%
2023-12-31$83.69M5.84%
2023-09-30$79.07M2.39%
2023-06-30$77.23M18.42%
2023-03-31$65.21M9.97%
2022-12-31$59.30M-12.45%
2022-09-30$67.73M3.85%
2022-06-30$65.22M22.81%
2022-03-31$53.11M-5.38%
2021-12-31$56.12M20.03%
2021-09-30$46.76M3.07%
2021-06-30$45.37M12.81%
2021-03-31$40.21M-2.90%
2020-12-31$41.41M-5.11%
2020-09-30$43.64M2.70%
2020-06-30$42.49M15.29%
2020-03-31$36.86M-19.36%
2019-12-31$45.71M17.55%
2019-09-30$38.88M29.74%
2019-06-30$29.97M36.85%
2019-03-31$21.90M122.69%
2018-12-31$9.84M100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31-100.00%
2017-12-31-100.00%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31-100.00%
2016-12-31-100.00%
2016-09-30-100.00%
2016-06-30-100.00%
2016-03-31-100.00%
2015-12-31-100.00%
2015-09-30-100.00%
2015-06-30-100.00%
2015-03-31-100.00%
2014-12-31-100.00%
2014-09-30-100.00%
2014-06-30-100.00%
2014-03-31-100.00%
2013-12-31-100.00%
2013-09-30--100.00%
2013-06-30$11.50M100.00%
2013-03-31-100.00%
2012-12-31-100.00%
2012-09-30-100.00%
2012-06-30-100.00%
2012-03-31--100.00%
2011-12-31$1.40M222.53%
2011-09-30$435.00K-55.52%
2011-06-30$978.00K-38.91%
2011-03-31$1.60M21.20%
2010-12-31$1.32M-26.90%
2010-09-30$1.81M-3.06%
2010-06-30$1.86M-3.37%
2010-03-31$1.93M-22.47%
2009-12-31$2.49M0.53%
2009-09-30$2.48M-18.59%
2009-06-30$3.04M28.27%
2009-03-31$2.37M-17.10%
2008-12-31$2.86M-29.77%
2008-09-30$4.07M53.74%
2008-06-30$2.65M14.29%
2008-03-31$2.32M8.17%
2007-12-31$2.14M-

Insmed generated $142.34M in revenue during Q3 2025, up 32.52% compared to the previous quarter, and up 157.56% compared to the same period a year ago.

Insmed Revenue Breakdown


Insmed Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 25Dec 24
Reportable Segment$606.42M$363.71M

Insmed's latest annual revenue breakdown by segment (product or service), as of Dec 25: Reportable Segment (100.00%).

Quarterly Revenue by Product

Product/ServiceDec 25Jun 25Mar 25
Reportable Segment$406.19M$107.42M$92.82M

Insmed's latest quarterly revenue breakdown by segment (product or service), as of Dec 25: Reportable Segment (100.00%).

Insmed Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 25Dec 24Dec 23Dec 22Dec 21
UNITED STATES$452.95M$254.80M$224.19M$185.99M$159.51M
Non-US$153.47M----
Europe And The Rest Of The World-$21.21M$15.28M$2.86M$12.95M
JAPAN-$87.70M$65.73M$56.51M$16.01M

Insmed's latest annual revenue breakdown by geography, as of Dec 25: UNITED STATES (74.69%), and Non-US (25.31%).

Quarterly Revenue by Country

CountryDec 25Sep 25Jun 25Mar 25Dec 24Sep 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22
Non-US$113.16M$40.31M-------------
UNITED STATES$217.96M$102.03M$68.68M$64.28M$131.58M$66.87M$56.35M$58.26M$59.20M$57.66M$49.07M$48.48M$49.54M$47.19M$3.53M
JAPAN--$30.67M$22.08M$51.83M$20.98M$14.89M$20.95M$16.03M$15.59M$13.16M$15.50M$14.48M$15.85M$10.68M
Europe And The Rest Of The World--$8.06M$6.46M$11.37M$5.57M$4.26M$4.48M$3.84M$3.97M$2.99M$-4.68M$3.71M$2.18M$-1.31M

Insmed's latest quarterly revenue breakdown by geography, as of Dec 25: UNITED STATES (65.82%), and Non-US (34.18%).

Insmed Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
TAKTakeda Pharmaceutical$4.26T$1.05T
CAHCardinal Health$222.58B$65.44B
HUMHumana$129.66B$32.65B
GEHCGE HealthCare$19.60B$5.14B
IQVIQVIA$16.31B$4.10B
HLNHaleon$11.30B$2.92B
ALCAlcon$10.09B$2.46B
AAgilent$6.83B$1.74B
RMDResMed$5.15B$1.42B
ONCBeOne Medicines$3.81B$1.32B
INSMInsmed$606.42M$142.34M

INSM Revenue FAQ


What is Insmed’s yearly revenue?

Insmed's yearly revenue for 2025 was $606.42M, representing an increase of 66.73% compared to 2024. The company's yearly revenue for 2024 was $363.71M, representing an increase of 19.17% compared to 2023. INSM's yearly revenue for 2023 was $305.21M, representing an increase of 24.39% compared to 2022.

What is Insmed’s quarterly revenue?

Insmed's quarterly revenue for Q3 2025 was $142.34M, a 32.52% increase from the previous quarter (Q2 2025), and a 52.36% increase year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $107.42M, a 15.72% increase from the previous quarter (Q1 2025), and a 18.90% increase year-over-year (Q2 2024). INSM's quarterly revenue for Q1 2025 was $92.82M, a -11.12% decrease from the previous quarter (Q4 2024), and a 22.94% increase year-over-year (Q1 2024).

What is Insmed’s revenue growth rate?

Insmed's revenue growth rate for the last 3 years (2023-2025) was 98.69%, and for the last 5 years (2021-2025) was 221.78%.

What are Insmed’s revenue streams?

Insmed's revenue streams in c 25 are Reportable Segment

What is Insmed’s main source of revenue?

For the fiscal year ending Dec 25, the largest source of revenue of Insmed was Reportable Segment. This segment made a revenue of $606.42M, representing 100.00% of the company's total revenue.